Boardroom Alpha
Meeting calendar
SKWD · Annual meeting · Tuesday, May 5, 2026

Skyward Specialty Insurance Group Inc

2 nominees · 3 ballot items.

Elect two Class I directors; advisory approval of named executive officer compensation (Say-on-Pay); ratify Ernst & Young LLP as independent registered public accounting firm for fiscal 2026.

Market cap
$2.5B
1Y TSR
+12.3%
Board grade
B
Record date
Mar 6, 2026
Filing
DEF 14A
Meeting concluded · May 5, 2026

Follow how the vote landed and what changed on Skyward Specialty Insurance Group Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Class I Directors

    ManagementBoard: FOR

    Elect two Class I directors to serve three-year terms expiring at the 2029 annual meeting.

  2. 2

    Advisory Vote to Approve Named Executive Officer Compensation (Say-On-Pay

    ManagementBoard: FOR

    Non-binding advisory approval of the compensation of the Company’s named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal asks shareholders to cast a non-binding advisory vote to approve the Company’s executive compensation disclosures and programs for the named executive officers (NEOs). The Board and Compensation Committee are seeking this vote in compliance with Dodd-Frank and SEC rules and to obtain shareholder feedback on the Company’s overall approach to pay-for-performance. Management explains that its executive pay framework emphasizes market-competitive base salaries, significant performance-based cash incentives tied to gross written premium growth and internal combined ratio, and long-term PSUs tied to relative growth in book value per share and multi-year combined ratio performance, with limits (e.g., maximum PSU payout of 150%) and governance guardrails such as clawbacks, stock ownership guidelines, and no hedging/pledging. The proposal is advisory only, so it will not bind the Compensation Committee or the Board, but the Board says it will consider the vote result in future compensation decisions. The Board unanimously recommends a vote FOR, citing the alignment of compensation with profitable growth, retention and shareholder alignment. Given Skyward’s strong operating results in 2025 and a prior 99.1% Say-on-Pay approval in 2025, shareholders should evaluate whether the disclosed compensation structure and metrics remain aligned with sustainable long-term value creation, how the recent Apollo acquisition and related pay changes impact incentive metrics and reference peer groups, and whether governance features (e.g., PSU caps, clawbacks, no single-trigger CIC vesting) sufficiently mitigate excessive risk-taking while incentivizing growth.

  3. 3

    Ratification of Selection of Ernst & Young LLP as Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2026.

Director elections

Nominees on the ballot2

Independent
Tenure on this board
3.0 yrs
Ownership

Top institutional holders10

Latest 13F quarter
1REINHART PARTNERS, LLC.6.9%2,780,784$121M
2PRICE T ROWE ASSOCIATES INC /MD/4.1%1,680,982$73M
3VANGUARD CAPITAL MANAGEMENT LLC4.1%1,669,432$73M
4Invesco Ltd.3.8%1,526,452$67M
5BlackRock, Inc.3.4%1,395,784$61M
6BlackRock, Inc.3.3%1,342,229$59M
7WESTWOOD HOLDINGS GROUP INC3.3%1,329,349$58M
8STATE STREET CORP2.6%1,050,677$46M
9Polar Capital Holdings Plc2.5%1,000,000$44M
10AMERICAN CENTURY COMPANIES INC2.4%975,027$43M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Skyward Specialty Insurance Group Inc 2026 annual meeting?
Skyward Specialty Insurance Group Inc (SKWD) holds its 2026 annual shareholder meeting on Tuesday, May 5, 2026.
What is the record date for the Skyward Specialty Insurance Group Inc 2026 meeting?
The record date for the Skyward Specialty Insurance Group Inc 2026 meeting is Friday, March 6, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Skyward Specialty Insurance Group Inc's 2026 meeting?
The board is presenting 2 director nominees at the Skyward Specialty Insurance Group Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Skyward Specialty Insurance Group Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Skyward Specialty Insurance Group Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer